Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,051 | -74,766 | -78,166 | -56,024 | 95,639 |
| Depreciation Amortization | 1,514 | 1,653 | 651 | 75 | 940 |
| Accounts receivable | -65 | -81 | -57 | 119 | -107 |
| Accounts payable and accrued liabilities | 2,264 | -651 | -217 | 435 | 113 |
| Other Working Capital | 7,833 | -10,725 | 16,048 | 3,970 | -2,473 |
| Other Operating Activity | 13,351 | 15,533 | 12,980 | 3,396 | 9,972 |
| Operating Cash Flow | $-55,154 | $-69,037 | $-48,761 | $-48,029 | $104,084 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 52,713 | 554 | 83,268 | 40,772 | -120,360 |
| PPE Investments | -255 | -210 | -685 | -2,869 | -947 |
| Investing Cash Flow | $52,458 | $344 | $82,583 | $37,903 | $-121,307 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 29,659 |
| Debt Repayment | N/A | N/A | N/A | N/A | -30,745 |
| Common Stock Issued | 67,130 | 92,852 | 2,076 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -740 | -1,206 | N/A |
| Other Financing Activity | 0 | 0 | 115 | 1,037 | 6,576 |
| Financing Cash Flow | $67,130 | $92,852 | $1,451 | $-169 | $5,490 |
| Beginning Cash Position | 78,359 | 54,200 | 18,927 | 29,222 | 40,955 |
| End Cash Position | 142,793 | 78,359 | 54,200 | 18,927 | 29,222 |
| Net Cash Flow | $64,434 | $24,159 | $35,273 | $-10,295 | $-11,733 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,154 | -69,037 | -48,761 | -48,029 | 104,084 |
| Capital Expenditure | -255 | -210 | -685 | -2,869 | -947 |
| Free Cash Flow | -55,409 | -69,247 | -49,446 | -50,898 | 103,137 |